Novartis announced on Monday that it will partner with Malaria No More and the Power of One campaign to provide two million pediatric antimalarial treatments in Zambia.
"Although the incidence of malaria has decreased, the disease still kills a child every minute in Africa," Novartis CEO Joseph Jimenez said. "Our commitment to Power of One reflects our company's long-term efforts to fight malaria and Novartis remains dedicated to controlling and ultimately eliminating this deadly disease."
The Power of One campaign began in September and is a digital fundraising effort to prevent child deaths from malaria around the world. Malaria is treatable and preventable, and controlling the disease is recognized as a priority by the World Health Organization.
"One and a half million treatments are already on the ground in Zambia thanks to the Power of One campaign, with a further 500,000 anticipated in the coming weeks," Malaria No More CEO Martin Edlund said. "Power of One is resonating with the general public, and their donations will help us ensure that children in Zambia will have access to the treatment they need."
Novartis pledged to match up to one million treatments gained by public funding through 2015. Since 2009, the company has provided more than 600 million treatments in malaria-endemic countries.